Garofalo Elizabeth A.
CIK 0001826361
Director
Filings
20
Latest Jun 3, 2026
Issuers covered
4
Showing
20 of 20
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 100% | +13.2% | +14.9% | +16.8% | +7.8% |
| 90 days | 3 | 67% | -0.0% | +3.3% | +18.2% | -21.6% |
| 180 days | 3 | 67% | -6.2% | +11.2% | +12.3% | -42.1% |
| 365 days | 2 | 50% | +1.0% | +1.0% | +25.9% | -23.9% |
Issuers
Companies where Garofalo Elizabeth A. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ACAD | Acadia Pharmaceuticals Inc | 8 | Jun 1, 2026 |
| XENE | Xenon Pharmaceuticals Inc. | 6 | Jun 3, 2026 |
| ALEC | Alector, Inc. | 5 | Jun 12, 2025 |
| XCUR | Exicure, Inc. | 1 | Jun 15, 2022 |
All filings
20 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|